These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 15162539)
21. [Effects of transforming growth factor-beta 3 gene transfer on type I collagen synthesis of hepatic stellate cells]. Zhou X; Yu J; Li Q; Qian W; Xu KS Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):43-8. PubMed ID: 18226343 [TBL] [Abstract][Full Text] [Related]
22. Remote delivery and expression of soluble type II TGF-beta receptor in muscle prevents hepatic fibrosis in rats. Nakamuta M; Morizono S; Tsuruta S; Kohjima M; Kotoh K; Enjoji M Int J Mol Med; 2005 Jul; 16(1):59-64. PubMed ID: 15942678 [TBL] [Abstract][Full Text] [Related]
23. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro. Tao YY; Wang QL; Shen L; Fu WW; Liu CH Exp Biol Med (Maywood); 2013 Nov; 238(11):1284-96. PubMed ID: 24006304 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis. de Gouville AC; Boullay V; Krysa G; Pilot J; Brusq JM; Loriolle F; Gauthier JM; Papworth SA; Laroze A; Gellibert F; Huet S Br J Pharmacol; 2005 May; 145(2):166-77. PubMed ID: 15723089 [TBL] [Abstract][Full Text] [Related]
26. [Effects of antisense RNA of connective tissue growth factor expressing plasmid on rat liver fibrosis]. Lu CH; Lu JX; Hua GP; Zhu J; Wang H; Huang JF; Gu MZ; Zhou Q; Ni RZ Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):118-21. PubMed ID: 17362637 [TBL] [Abstract][Full Text] [Related]
27. [Effects of transforming growth factor beta1 on the proliferation and type I collagen expression at different differential rat hepatic stellate cells]. Liu CH; Xan HP Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):731-4. PubMed ID: 14697134 [TBL] [Abstract][Full Text] [Related]
28. Relation of type II transforming growth factor-beta receptor to hepatic fibrosis and hepatocellular carcinoma. Ueno T; Hashimoto O; Kimura R; Torimura T; Kawaguchi T; Nakamura T; Sakata R; Koga H; Sata M Int J Oncol; 2001 Jan; 18(1):49-55. PubMed ID: 11115538 [TBL] [Abstract][Full Text] [Related]
29. Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats. Marquez-Aguirre A; Sandoval-Rodriguez A; Gonzalez-Cuevas J; Bueno-Topete M; Navarro-Partida J; Arellano-Olivera I; Lucano-Landeros S; Armendariz-Borunda J J Gene Med; 2009 Mar; 11(3):207-19. PubMed ID: 19189315 [TBL] [Abstract][Full Text] [Related]
30. Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Dooley S; Delvoux B; Lahme B; Mangasser-Stephan K; Gressner AM Hepatology; 2000 May; 31(5):1094-106. PubMed ID: 10796885 [TBL] [Abstract][Full Text] [Related]
31. Inhibition on the production of collagen type I, III of activated hepatic stellate cells by antisense TIMP-1 recombinant plasmid. Liu WB; Yang CQ; Jiang W; Wang YQ; Guo JS; He BM; Wang JY World J Gastroenterol; 2003 Feb; 9(2):316-9. PubMed ID: 12532457 [TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma. Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856 [TBL] [Abstract][Full Text] [Related]
33. Enhanced effect of soluble transforming growth factor-beta receptor II and IFN-gamma fusion protein in reversing hepatic fibrosis. Yao H; Pan J; Qian Y; Pei Z; Bader A; Brockmeyer NH; Altmeyer P; Zhang L Eur J Med Res; 2010 Apr; 15(4):152-61. PubMed ID: 20554496 [TBL] [Abstract][Full Text] [Related]
34. HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1. Shin JY; Hur W; Wang JS; Jang JW; Kim CW; Bae SH; Jang SK; Yang SH; Sung YC; Kwon OJ; Yoon SK Exp Mol Med; 2005 Apr; 37(2):138-45. PubMed ID: 15886528 [TBL] [Abstract][Full Text] [Related]
35. Treatment of pig serum-induced rat liver fibrosis with Boschniakia rossica, oxymatrine and interferon-alpha. Wu CS; Piao XX; Piao DM; Jin YR; Li CH World J Gastroenterol; 2005 Jan; 11(1):122-6. PubMed ID: 15609410 [TBL] [Abstract][Full Text] [Related]
36. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines. Wikström P; Lindh G; Bergh A; Damber JE Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820 [TBL] [Abstract][Full Text] [Related]
37. Antifibrotic effects of protocatechuic aldehyde on experimental liver fibrosis. Li C; Jiang W; Zhu H; Hou J Pharm Biol; 2012 Apr; 50(4):413-9. PubMed ID: 22129045 [TBL] [Abstract][Full Text] [Related]
38. The expression of CSRP2 encoding the LIM domain protein CRP2 is mediated by TGF-beta in smooth muscle and hepatic stellate cells. Herrmann J; Borkham-Kamphorst E; Haas U; Van de Leur E; Fraga MF; Esteller M; Gressner AM; Weiskirchen R Biochem Biophys Res Commun; 2006 Jul; 345(4):1526-35. PubMed ID: 16735029 [TBL] [Abstract][Full Text] [Related]
39. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways. Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168 [TBL] [Abstract][Full Text] [Related]
40. Aberrant TGF-β1 signaling contributes to the development of primary biliary cirrhosis in murine model. Liu B; Zhang X; Zhang FC; Zong JB; Zhang W; Zhao Y World J Gastroenterol; 2013 Sep; 19(35):5828-36. PubMed ID: 24124327 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]